Novo Nordisk, the maker of weight loss drug Wegovy, will lay off about 9,000 people as it grapples with rising competition in ...

Drugmaker Eli Lilly said on Tuesday it is launching an artificial intelligence and machine learning platform that provides ...

In recent years, Lilly's top line has been growing at a much faster pace thanks to its already approved GLP-1 injections, ...

Lila Biologics, a spinoff from Nobel Laureate David Baker’s research at the University of Washington, is collaborating with ...

Takeda names Rhonda Pacheco as U.S. Business Unit President, bringing expertise from Eli Lilly. Read more here.

Wall St. provides estimates for future stock prices of Eli Lilly from 2025 to 2030 based on projected revenue and net income.

Eli Lilly's new TuneLab platform gives biotech firms AI-powered drug discovery tools using $1 billion of proprietary research ...

Eli Lilly dominates obesity and diabetes treatments with soaring tirzepatide sales and promising oral drug data. Find out why ...

Lilly, which sells the Alzheimer’s drug Kisunla, has recruited Moore to its global “Brain Health Matters” campaign. Drawing ...

Eli Lilly (NYSE: LLY) stock has soared in the triple digits over the past three years thanks to one particular product line: ...

Eli Lilly is inviting early-stage biotechs to make use of drug discovery models that the pharma is providing via a new AI platform. | Eli Lilly is inviting early-stage biotechs to make use of drug ...

Eli Lilly said a third late-stage study of its experimental anti-obesity pill hit its key goals, paving the way for the ...